Skip to main content
TechReportedMedium
5.0

Merck partners with Isomorphic Labs on AI drug design

Merck announced a research collaboration with Isomorphic Labs, the AI drug discovery firm built on DeepMind's AlphaFold technology. The deal signals continued pharma investment in AI-driven target discovery, though financial terms and specific therapeutic areas are not disclosed. It underscores the growing integration of AI into early-stage drug R&D pipelines.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

STAT Newsabout 9 hours agoUS, GBengCredibility 19%View source

Score Breakdown

Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.2

Intelligence Tags

Entities

United StatescountryUnited Kingdomcountry
Source

Related signals

8 found